Pharmacology, Toxicology and Pharmaceutical Science
microRNA 122
100%
Biological Marker
96%
microRNA
57%
Microsphere
53%
Hepatitis B
50%
Toxic Hepatitis
50%
Liver Injury
50%
Surface Plasmon Resonance
50%
Hepatitis B Antigen
50%
Buffer
25%
Immunoassay
25%
N-(2-Hydroxypropyl) Methacrylamide
25%
Methacrylamide
25%
Malignant Neoplasm
14%
Disease
14%
Phycoerythrin
13%
Small Untranslated RNA
7%
Streptavidin
7%
Liver Disease
7%
Base
7%
Adverse Event
7%
Immunology and Microbiology
Chemical Labeling
50%
Surface Plasmon Resonance
50%
Hepatitis B Antigen
50%
Immune-Mediated Inflammatory Diseases
50%
Hepatitis B
50%
Ulcerative Colitis
50%
Immunology
50%
HBsAg
50%
Blood Plasma
37%
Atopic Dermatitis
37%
Immunoassay
25%
Immune Dysregulation
12%
Normal Human
12%
Immune Response
12%
Biological Product
12%
Organ Systems
12%
Coronary Artery
12%
RNA Sequence
12%
Experimental Model
12%
Medicine and Dentistry
Biological Marker
64%
Diagnosis
57%
Microsphere
53%
microRNA 122
50%
microRNA
50%
Liquid Biopsy
50%
Toxic Hepatitis
50%
DNA Methylation
14%
Diseases
14%
Malignant Neoplasm
14%
Gene Expression
7%
Cell Proliferation
7%
Programmed Cell Death
7%
Streptavidin
7%
Phycoerythrin
7%
Small Untranslated RNA
7%
Liver Disease
7%
Liver Function
7%
Biological Phenomena and Functions Concerning the Entire Organism
7%
Multiplexing
7%
Drug Withdrawal
7%
Diagnostic Accuracy
7%
Cost-Effectiveness Analysis
7%
Patient Care
7%
Base
7%
Adverse Event
7%